Advanced search
Start date

Development of powdered Levofloxacin loaded NLC by advanced processing techniques

Grant number: 23/08201-7
Support Opportunities:Scholarships abroad - Research Internship - Scientific Initiation
Effective date (Start): May 31, 2024
Effective date (End): August 30, 2024
Field of knowledge:Health Sciences - Pharmacy
Principal Investigator:Laura de Oliveira Nascimento
Grantee:Samira Elisa Alves Geraldo
Supervisor: Hugh David Charles Smyth
Host Institution: Faculdade de Ciências Farmacêuticas (FCF). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Research place: University of Texas at Austin (UT), United States  
Associated to the scholarship:22/05047-4 - Evaluation of the influence of surfactants from lipid nanoparticles on their physicochemical, antimicrobial and cellular interaction, BP.IC


The pulmonary drug delivery can benefit local therapy for lung diseases by promoting high concentration of the drug in the site of action and rapid effect onset. Concerning treatment of bacterial infections, Levofloxacin (fluoroquinolone) stands out as a broad-spectrum agent and effective for invasions of the respiratory tract; it has also pulmonary delivery approved by European Union and Canada. However, pulmonary delivery has challenges: endogenous defense mechanisms, large surface area contributing to systemic distribution of drugs and particle size effects. Studies with nanoparticles of levofloxacin for drug delivery present satisfactory results, and a promising option for delivery is the Nanostructured lipid carrier (NLC). This colloidal drug delivery system may increase mucus penetration, offer prolonged drug release and targeting. The NLC were previously developed in the project FAPESP nº 2018/03666-3 had high encapsulation efficiency and good physicochemical parameters, but susceptible to oxidation of levofloxacin in suspension form. Powdered dosage forms are preferred in pharmaceutical formulation development due to good stability, lower volume, convenience in administration and avoidance of the cold chain. Therefore, the following project proposes the development of powdered NLC Levofloxacin by advanced processing techniques (Thin film freezing and spray freeze drying) evaluating particle parameters (Zeta potencial, PDI size and morphology), powder characteristics and drug parameters (Levofloxacin quantification and encapsulation efficiency).

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.